This paper is in the following e-collection/theme issue:

mHealth for Screening (221) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1428) mHealth for Telemedicine and Homecare (418) mHealth for Wellness, Behavior Change and Prevention (2922) Usability of Apps and User Perceptions of mHealth (993) Use and User Demographics of mHealth (344) Mobile Health (mhealth) (2982) Skin Cancer and Melanoma Prevention (113) Innovations and Technology in Cancer Care (431) Innovations and Technology for Cancer Prevention and Screening (150) Mobile Apps for Cancer Care and Cancer Prevention and Screening (210)

Published on in Vol 9, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/22909, first published .
Digital Natives’ Preferences on Mobile Artificial Intelligence Apps for Skin Cancer Diagnostics: Survey Study

Digital Natives’ Preferences on Mobile Artificial Intelligence Apps for Skin Cancer Diagnostics: Survey Study

Digital Natives’ Preferences on Mobile Artificial Intelligence Apps for Skin Cancer Diagnostics: Survey Study

Authors of this article:

Sarah Haggenmüller1 Author Orcid Image ;   Eva Krieghoff-Henning1 Author Orcid Image ;   Tanja Jutzi1 Author Orcid Image ;   Nicole Trapp1 Author Orcid Image ;   Lennard Kiehl1 Author Orcid Image ;   Jochen Sven Utikal2, 3 Author Orcid Image ;   Sascha Fabian4 Author Orcid Image ;   Titus Josef Brinker1 Author Orcid Image
Article Authors Cited by (15) Tweetations (3) Metrics

Sarah Haggenmüller   1 , MSc ;   Eva Krieghoff-Henning   1 , PhD ;   Tanja Jutzi   1 , PhD ;   Nicole Trapp   1 ;   Lennard Kiehl   1 , BSc ;   Jochen Sven Utikal   2, 3 , MD ;   Sascha Fabian   4 , PhD ;   Titus Josef Brinker   1 , MD

1 Digital Biomarkers for Oncology Group, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany

2 Department of Dermatology, Heidelberg University, Mannheim, Germany

3 Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany

4 Department of Economics, University of Applied Science Neu-Ulm, Neu-Ulm, Germany

Corresponding Author:

  • Titus Josef Brinker, MD
  • Digital Biomarkers for Oncology Group
  • National Center for Tumor Diseases
  • German Cancer Research Center
  • Im Neuenheimer Feld 280
  • Heidelberg, 69120
  • Germany
  • Phone: 49 6221 32 19 304
  • Email: titus.brinker@dkfz.de